Last reviewed · How we verify

NCT06933745: P-SONAR

Ultrasound Assessment of Atherosclerotic Plaque Burden and Cardiovascular Risk: A 10-Year Prospective Study

Completed Last updated 22 April 2025
What this trial tests

trial in Cardiovascular Diseases in 21,029 participants. Completed in 1 March 2025.

Timeline
1 April 2022
Primary endpoint
1 March 2025
1 March 2025

Quick facts

Lead sponsorUniversity Hospital, Akershus
StatusCompleted
Study typeOBSERVATIONAL
Enrollment21,029
Start date1 April 2022
Primary completion1 March 2025
Estimated completion1 March 2025
Sites1 location across Norway

Conditions studied

Sponsor

University Hospital, Akershus

Who can join

Adults 45 to 74, any sex, with Cardiovascular Diseases or Fatty Liver. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The P-SONAR study is a large, observational, prospective cohort study. The overall aim of the study is to investigate whether plaque burden estimation by 2D ultrasound of the carotid and femoral arteries may enhance cardiovascular risk prediction beyond NORRISK-2

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Discriminating established cardiovascular disease using a novel multiterritory ultrasound plaque burden measure (wTPT): findings from the P-SONAR study.
    Austad G, Geitung JT, Thomas O, Tonstad S. · · 2026 · PMID 41952119 · DOI 10.1186/s12872-026-05807-8
  2. Association between a novel ultrasound-based measure of plaque burden and cardiovascular risk: the P-SONAR study.
    Austad G, Geitung JT, Thomas O, Tonstad S. · · 2026 · PMID 41669413 · DOI 10.21037/qims-2025-1566
  3. Discriminating Established Cardiovascular Disease Using a Novel Multiterritory Ultrasound Plaque Burden Measure (wTPT): Findings From the P-SONAR Study
    Austad G, Geitung JT, Thomas O, Tonstad S. · · 2025 · DOI 10.21203/rs.3.rs-8215491/v1

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other University Hospital, Akershus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06933745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing